Oslo, Norway

Jessie Sandosham

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Nycomed Imaging as. Active years: 1998-2000.


% Patents Active = 100.0


Average Co-Inventor Count = 5.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jessie Sandosham: Innovator in Cell Proliferation Regulation

Introduction

Jessie Sandosham is a prominent inventor based in Oslo, Norway. She has made significant contributions to the field of biotechnology, particularly in the area of cell proliferation regulation. With a total of 3 patents to her name, her work has the potential to impact various medical applications.

Latest Patents

One of her latest patents is focused on pyrazinedicarboxylic-acid derivatives as cell proliferation regulators. This invention relates to novel pyrazine compounds and their use in the regulation of haematopoiesis, specifically in stimulating haematopoiesis and treating bacterial, viral, and fungal diseases. Another notable patent involves a pyrazine fused to a cyclic peptide, showcasing her innovative approach to complex chemical structures.

Career Highlights

Throughout her career, Jessie has worked with notable companies such as Nycomed Imaging AS and GE Healthcare AS. Her experience in these organizations has allowed her to develop and refine her inventions, contributing to advancements in medical technology.

Collaborations

Jessie has collaborated with esteemed colleagues, including Johann Hiebl and Hermann Kollmann. These partnerships have further enriched her research and development efforts.

Conclusion

Jessie Sandosham is a trailblazer in the field of biotechnology, with her innovative patents paving the way for advancements in medical treatments. Her work exemplifies the impact of dedicated inventors in improving healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…